Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOME II: Bosentan in systemic sclerosis patients with early or active nailfold capillaroscopic pattern
2011-005303-32Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in systemic sclerosis (SSc), digital ulcer (DU), sponsored by Actelion Pharmaceuticals Ltd. Started Jan 2012; status: completed.
02
Drugs
bosentan
03
Conditions
systemic sclerosis (SSc)digital ulcer (DU)
Beyond the preview
Go deeper on 2011-005303-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005303-32.